Before, during, or after your injection—no matter when you have questions, we’re available to help you manage your RMS therapy with helpful tips and tools.

Preparation tips for injecting Teva's COPAXONE®:

Set up a free 1-on-1 injection training. Even if you have used an injectable therapy before, you should be trained by a doctor or nurse before you inject COPAXONE ® for the first time. Call Teva’s Shared Solutions ® at 1-800-887-8100 or visit and request to speak with one of our MS-certified nurses. Your session can be as short or as long as you need it to be.

Organize your supplies

Download our Injection Guide for easy-to-reference materials you can print out to use when injecting. Start by placing each item you'll need on a clean, flat surface 1:

  • 1 COPAXONE ® prefilled syringe

  • The auto ject ®2 for glass syringe (if you're using it)

  • A warm compress (if you're using it)

  • An alcohol wipe

  • A dry cotton ball

  • A used-syringe disposal container

Before Injecting

When Injecting

After Injecting

  • Always wash your hands before injecting.1

  • Remember—wait 20 minutes until your prefilled syringe has reached room temperature before injecting.1

  • Some people find it helpful to use a warm compress before injecting.

  • Always use a cloth barrier between bare skin and the warm compress.

  • Do not use the warm compress in areas where sensation of temperature is impaired.

  • Alternatively, it may help to ice the site for 1 minute before cleaning the site and injecting.

  • Clean your injection site with an alcohol wipe, and make sure your skin is dry before injecting.1

  • Rotation matters. It is extremely important to rotate your injection areas (and sites within each area) to help keep your skin as healthy as possible.1

A diagram of the three injection sites located on the front of the body and a diagram of the four injection sites on the back of the body for COPAXONE® therapy.

  • There are 7 injection areas to rotate between. Download the COPAXONE iTracker® 2.0 app to keep track of your injection areas, and be sure that you do not inject in the same place (site) more than 1 time each week.1

  • Your doctor may be able to recommend other appropriate injection sites, if needed. To make an appointment for a free 1-on-1 injection training when you start COPAXONE® therapy, call Teva’s Shared Solutions® at 1-800-887-8100.

  • Depth matters. If using the autoject®2 for glass syringe, different areas of your body may require different depth settings. Using depth settings that are too deep or too shallow may contribute to injection site reactions. Finding the right depth setting for each injection area can help make your injections more comfortable.

  • Avoid injecting into sites with birthmarks, tattoos, stretch marks and scars and/or other skin irregularities.1,2

  • If there are particles in the syringe or the solution is cloudy, do not use it.1 Report this event to Teva’s Shared Solutions®.

  • Never inject with a needle that has been dropped on the floor or has come in contact with any other surface. Start over with a new syringe.

  • Avoid hot showers or baths after you inject.

  • Do not massage the site immediately after injecting—this can damage underlying tissue. Wait at least 24 hours after injecting.2

  • Dispose of used syringes in a hard-walled plastic or disposable biohazard sharps container immediately after you inject.1

  • If you miss a dose, take your COPAXONE® as soon as you remember. If it is nearer to the time of your next scheduled dose, skip the missed dose and resume your usual dosing schedule.

  • If you have any questions about missing a dose, contact Teva’s Shared Solutions® at 1-800-887-8100 or your healthcare provider for assistance.

Please read the Patient Information in the full Prescribing Information.


  1. COPAXONE® (glatiramer acetate injection) Current Prescribing Information Parsippany, NJ. Teva Neuroscience, Inc.

  2. McEwan L, Brown J, Poirier J, et al. Best practices in skin care for the multiple sclerosis patient receiving injectable therapies. Int J MS Care. 2010;12(4):177-189. doi:10.7224/1537-2073-12.4.177

You are about to leave and enter a website operated by a third party.

Would you like to continue?

The information on this site is intended for healthcare professionals in the United States. Are you a healthcare professional in the United States?